Advertisement

Evaluating the effectiveness of two bovine mastitis vaccines and their influences on oxidant and antioxidant capacities of milk

  • Niloufar Tashakkori
  • Babak KhoramianEmail author
  • Mehran Farhoodi Moghadam
  • Mohamad Heidarpour
  • Komeil Mashayekhi
  • Nima Farzaneh
Regular Articles

Abstract

The aim of the current study was to investigate the efficacy of two commercial mastitis vaccines (Startvac® and Mastivac®) and their influence on oxidant and antioxidant capacities of milk samples in a dairy farm. A total of 165 Holstein dairy cows were recruited into the study and were divided into Startvac®, Mastivac®, and control groups. The effects on the incidence and severity of clinical mastitis cases, duration of treatment, infection status, bacteriologic culture, somatic cell count, 5-thio-2-nitrobenzoic acid assay and ferric reducing antioxidant power assay, incidence of metritis and endometritis, and milk yield were evaluated within the first 90 days of lactation. The incidence of clinical mastitis was not significantly different among groups. The mean SCCs during the first, second, and third months of lactation did not differ significantly. The percentage of cured cows did not differ significantly. TNB and FRAP assays were used to know whether or not vaccination against mastitis has an effect on oxidant and antioxidant capacity of milk samples, which did not differ significantly. In conclusion, we observed no significant difference in the abovementioned variables. However, it is possible that applying mastitis vaccines within the specific conditions may have positive effects considering the results of previous studies.

Keywords

Mastitis Vaccine Dairy cow Oxidant and antioxidant capacities 

Abbreviations

TNB

Thio-nitrobenzoate

FRAP

Ferric reducing antioxidant power

SCC

Somatic cell count

TOC

Total oxidant capacity

TAC

Total antioxidant capacity

S. aureus

Staphylococcus aureus

E. coliEscherichia coli

CNS

Coagulase-negative staphylococci

Notes

Acknowledgments

The authors would like to gratefully acknowledge Mr. A. Kargar for his assistance in this project; also, Startvac® and Mastivac® vaccines were kind gifts of Sorur Fajr Co. and Nikan Pakhsh Behparvar companies (Tehran, Iran), respectively.

Funding

This work was supported by the Ferdowsi University of Mashhad (Grant number 3/39422, December/20/2015). Funding was allocated to collection, analysis and interpretation of data.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Atakisi, O., Oral, H., Atakisi, E., Merhan, O., Pancarci, S. M., Ozcan, A., Marasli, S., Polat, B., Colak, A. & Kaya, S. 2010. Subclinical mastitis causes alterations in nitric oxide, total oxidant and antioxidant capacity in cow milk. Research in Veterinary Science, 89, 10-13.CrossRefGoogle Scholar
  2. Barlund, C., Carruthers, T., Waldner, C. & PALMER, C. 2008. A comparison of diagnostic techniques for postpartum endometritis in dairy cattle. Theriogenology, 69, 714-723.CrossRefGoogle Scholar
  3. Bradley, A. J., Breen, J., Payne, B., White, V. & Green, M. J. 2015. An investigation of the efficacy of a polyvalent mastitis vaccine using different vaccination regimens under field conditions in the United Kingdom. Journal of Dairy Science, 98, 1706-1720.CrossRefGoogle Scholar
  4. Council, N. M. 1999. Laboratory handbook on bovine mastitis. NMC Inc., Madison.Google Scholar
  5. Erskine, R. 2012. Vaccination strategies for mastitis. Veterinary Clinics: Food Animal Practice, 28, 257-270.Google Scholar
  6. Freick, M., Frank, Y., Steinert, K., Hamedy, A., Passarge, O. & Sobiraj, A. 2016a. Mastitis vaccination using a commercial polyvalent vaccine or a herd-specific Staphylococcus aureus vaccine. Tierärztliche Praxis Ausgabe G: Großtiere/Nutztiere, 44, 219-229.CrossRefGoogle Scholar
  7. Freick, M., Frank, Y., Steinert, K., Hamedy, A., Passarge, O. & Sobiraj, A. 2016b. Mastitis vaccination using a commercial polyvalent vaccine or a herd-specific Staphylococcus aureus vaccine. Tierärztliche Praxis G: Großtiere/Nutztiere, 44, 219-229.Google Scholar
  8. Hernández-Castellano, L. E., Wall, S., Stephan, R., Corti, S. & Bruckmaier, R. 2017. Milk somatic cell count, lactate dehydrogenase activity, and immunoglobulin G concentration associated with mastitis caused by different pathogens: A field study. Schweiz. Arch. Tierheilkd, 159, 283-290.CrossRefGoogle Scholar
  9. Kusebauch, U., Hernández-Castellano, L. E., Bislev, S. L., Moritz, R. L., Røntved, C. M. & Bendixen, E. 2018. Selected reaction monitoring mass spectrometry of mastitis milk reveals pathogen-specific regulation of bovine host response proteins. Journal of Dairy Science, 101, 6532-6541.CrossRefGoogle Scholar
  10. Landin, H., Mörk, M. J., Larsson, M. & Waller, K. P. 2015. Vaccination against Staphylococcus aureus mastitis in two Swedish dairy herds. Acta Veterinaria Scandinavica, 57, 81.CrossRefGoogle Scholar
  11. Leitner, G., Lubashevsky, E., Glickman, A., Winkler, M., Saran, A. & Trainin, Z. 2003. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows: I Challenge trials. Veterinary Immunology and Immunopathology, 93, 31-38.CrossRefGoogle Scholar
  12. Piepers, S., Prenafeta, A., Verbeke, J., DE Visscher, A., March, R. & DE Vliegher, S. 2017. Immune response after an experimental intramammary challenge with killed Staphylococcus aureus in cows and heifers vaccinated and not vaccinated with Startvac, a polyvalent mastitis vaccine. Journal of Dairy Science, 100, 769-782.CrossRefGoogle Scholar
  13. Ruegg, P. 2001. Evaluating the effectiveness of mastitis vaccines. UW Milk Quality.Google Scholar
  14. Schukken, Y., Bronzo, V., Locatelli, C., Pollera, C., Rota, N., Casula, A., Testa, F., Scaccabarozzi, L., March, R. & Zalduendo, D. 2014. Efficacy of vaccination on Staphylococcus aureus and coagulase-negative staphylococci intramammary infection dynamics in 2 dairy herds. Journal of Dairy Science, 97, 5250-5264.CrossRefGoogle Scholar
  15. Silanikove, N., Merin, U., Shapiro, F. & Leitner, G. 2014. Subclinical mastitis in goats is associated with upregulation of nitric oxide-derived oxidative stress that causes reduction of milk antioxidative properties and impairment of its quality. Journal of dairy science, 97, 3449-3455.CrossRefGoogle Scholar
  16. Talbot, B. G. & Lacasse, P. 2005. Progress in the development of mastitis vaccines. Livestock production science, 98, 101-113.CrossRefGoogle Scholar
  17. Wall, S. K., Hernández-Castellano, L. E., Ahmadpour, A., Bruckmaier, R. M. & Wellnitz, O. 2016. Differential glucocorticoid-induced closure of the blood-milk barrier during lipopolysaccharide-and lipoteichoic acid-induced mastitis in dairy cows. Journal of Dairy Science, 99, 7544-7553.CrossRefGoogle Scholar
  18. Wilson, D. J., Grohn, Y., Bennett, G., González, R., Schukken, Y. & Spatz, J. 2007. Comparison of J5 vaccinates and controls for incidence, etiologic agent, clinical severity, and survival in the herd following naturally occurring cases of clinical mastitis. Journal of Dairy Science, 90, 4282-4288.CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Department of Clinical Sciences, Faculty of Veterinary MedicineFerdowsi University of MashhadMashhadIran
  2. 2.Department of Clinical Sciences, Faculty of Veterinary Medicine, Karaj BranchIslamic Azad UniversityKarajIran
  3. 3.Quds Razavi Industrial Animal Husbandry InstituteMashhadIran

Personalised recommendations